Background. High levels of interferon gamma-induced protein (IP10) associate with rapid disease progression, chronic immune activation and HIV-1 replication in adults; however, the association of this cytokine with HIV disease in perinatally HIV infected children and adolescents, is not established.
Methods. We measure plasma IP10 levels by Luminex and CD8+ T cell activation (HLA-DR+ and CD38+) by flow cytometry. HIV+ patients are parsed into viremic (n = 28) and aviremic (n = 11) (HIV RNA < 400 or ≥ 400 copies/ml). Wilcoxon rank-sum is used to compare groups and Spearman's coefficient is used for correlation analysis. Results. 39 HIV+ on cARV [median CD4 % 30.2 IQR (23.2-39.4) and HIV RNA1.8 log 10 (1.6-3.0) copies/ml] and 14 HIV-are studied. HIV+ have significant higher concentrations of IP10 compared with HIV-(P < 0.0001); especially viremic individuals (Table 1) . We observe significantly higher % of T cell activation markers inviremic compared with aviremic (Table 1 ). Higher levels of IP10 correlate with higher CD38 % and HLA-DR and lower CD4 % (Table 2) . Lastly, early cARV therapy correlates with lower levels of IP10, CD8 %, CD8+ HLA-DR %, and higher CD4 % (Table 2) .
Conclusion. Perinatally HIV infected children and adolescents have a pattern of IP10 elevation comparable to HIV infected adults. Notably, IP10, a product of monocytes and dendritic cells, is significantly elevated-especially in viremic children-and associates with T cell activation and low CD4 %. The results support the view that IP10 is secreted in part as a direct effect of viral replication. Furthermore, our data suggest that early initiation of cARV might help to prevent immune system activation and disease progression in this population.
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